Developer of the Only Non-Hormonal Therapy for HSDD in Women Announces S1P-205, the Only Therapy for HSDD in Men Jersey City, NJ — May 14, 2012 —S1 Biopharma, an early-stage biopharmaceutical company developing therapeutic solutions for Hypoactive Sexual Desire Disorder…
Read more ›